Parascaris equorum
The ascarid nematode Parascaris equorum occurs in horses around the world, including Canada.
Summary
Many horses infected with P. equorum never show any clinical signs but heavy infections in young animals can significantly interfere with growth and development and in older animals can result in loss of condition and energy and sometimes gastro-intestinal signs. Rarely large numbers of adult parasites will obstruct the intestine (this can happen after treatment with an antiparasitic drug), and single adults can obstruct the bile duct or pancreatic duct. Horses of any age that are immunosuppressed and kept in sub-optimal environments are particularly susceptible to the development of heavy P. equorum infections.
Although there are several drugs that are effective against the life cycle stages of P. equorum in the gut lumen, treatment and control can be problematic. First, the adult females can produce very large numbers of eggs and the eggs are sticky and very resistant to adverse environmental conditions. Second, ivermectin resistance has been detected in P. equorum in Europe, the United States and eastern Canada, resistance to moxidectin has been demonstrated in Canada and elsewhere, and resistance to the macrocyclic lactones and pyrantel in the southern United States..
Parascaris equorum is not known to be zoonotic.
Taxonomy
Phylum: Nematoda
Order: Ascaridida
Superfamily: Ascaridoidea
Family: Ascarididae
Among parasites of veterinary importance related to P. equorum are Ascaris suum of pigs, and Toxocara species and Toxascaris leonina of dogs, cats and other carnivores. Another close relative is the human ascarid, Ascaris lumbricoides. All these ascarids live as adults in the small intestines of their hosts and all have similar life cycles.
Morphology
Eggs of P. equorum measure approximately 100 µm in diameter, and when freshly passed are yellow-brown and have a thick, rough outer shell layer and contain one or two cells. Sometimes during fecal flotation the outer rough layer is lost, and the eggs appear smooth.
Host range and geographic distribution
Life cycle - direct
Life Cycle: Parascaris equorum
Epidemiology
Pathology and clinical signs
Diagnosis
Treatment and control
There are several products approved in Canada for the treatment of Parascaris equorum in horses. Some are also effective for the migrating larvae. There is recent evidence from Europe and from North America and elsewhere that some P. equorum have developed resistance to ivermectin and/or moxidectin. In addition, P. equorum resistant to macrocyclic lactones and pyrantel has recently been discovered in the southern United States.
Drug(s) |
Product(s) |
PANACUR, SAFE-GUARD |
|
EQVALAN, BIMECTIN, EQUELL, PANOMEC |
|
Ivermectin with Praziquantel |
EQVALAN GOLD, EQUIMAX |
QUEST |
|
Moxidectin with Praziquantel |
QUEST PLUS |
ANTHELCIDE |
|
VARIOUS |
|
STRONGID T, STRONGID P, EXODUS |
Additional information is on the products mentioned is available from the Compendium of Veterinary Products (Twelfth Edition, 2011), or from the manufacturers.
Successful control of P. equorum depends on treatments to remove the adult (and larval) parasites, and thus the source of eggs, and to create an environment for the horses that minimizes their exposure to infective eggs.
Public health significance
References
Reinemeyer C (2009) Diagnosis and control of anthelmintic resistant Parascaris equorum. Parasites and Vectors 2 (Supplement 2) S8.
Slocombe JOD et al. (2007) Macrocyclic lactone-resistant Parascaris equorum on stud farms in Canada, and effectiveness of fenbendazole and pyrantel pamoate. Veterinary Parasitology 145: 371-376.